{
    "score": [
        0.9090909090909091
    ],
    "extracted": [
        0
    ],
    "abstract": [
        "brokerages expect lemaitre vascular inc to post $ 0.19 eps ."
    ],
    "id": "865026.train",
    "article": [
        "wall street brokerages expect lemaitre vascular inc to announce $ 0.19 earnings per share for the current quarter , according to zacks . two analysts have provided estimates for lemaitre vascular 's earnings , with the lowest eps estimate coming in at $ 0.19 and the highest estimate coming in at $ 0.20 . lemaitre vascular posted earnings of $ 0.13 per share during the same quarter last year , which suggests a positive year over year growth rate of 46.2 % . the firm is scheduled to announce its next quarterly earnings report on tuesday , february 20th . ",
        "on average , analysts expect that lemaitre vascular will report full year earnings of $ 0.84 per share for the current year . for the next financial year , analysts expect that the firm will report earnings of $ 0.87 per share , with eps estimates ranging from $ 0.79 to $ 0.93 . zacks investment research 's earnings per share calculations are a mean average based on a survey of research firms that follow lemaitre vascular . lemaitre vascular last released its earnings results on thursday , october 26th . the medical instruments supplier reported $ 0.25 eps for the quarter , beating the thomson reuters ' consensus estimate of $ 0.20 by $ 0.05 . ",
        "the firm had revenue of $ 24.80 million during the quarter , compared to analyst estimates of $ 25.49 million . lemaitre vascular had a return on equity of 16.16 % and a net margin of 15.81 % . the business 's quarterly revenue was up 6.9 % compared to the same quarter last year . during the same period in the prior year , the firm posted $ 0.17 earnings per share . lmat has been the subject of several analyst reports . zacks investment research upgraded lemaitre vascular from a `` hold '' rating to a `` buy '' rating and set a $ 35.00 target price for the company in a research note on thursday , december 28th . ",
        "canaccord genuity reiterated a `` hold '' rating and issued a $ 30.00 target price on shares of lemaitre vascular in a research note on monday , october 9th . bidaskclub lowered lemaitre vascular from a `` sell '' rating to a `` strong sell '' rating in a research note on wednesday , december 27th . first analysis lowered lemaitre vascular from an `` overweight '' rating to an `` equal weight '' rating and set a $ 34.00 target price for the company . in a research note on friday , october 27th . finally , benchmark lowered lemaitre vascular from a `` buy '' rating to a `` hold '' rating in a research note on friday , october 27th . ",
        "one research analyst has rated the stock with a sell rating , six have assigned a hold rating and one has assigned a buy rating to the stock . the stock currently has a consensus rating of `` hold '' and a consensus price target of $ 32.20 . in other lemaitre vascular news , insider david b. roberts sold 4,123 shares of the company 's stock in a transaction dated monday , november 6th . the stock was sold at an average price of $ 32.14 , for a total transaction of $ 132,513.22 . following the completion of the sale , the insider now directly owns 24,482 shares in the company , valued at $ 786,851.48 . ",
        "the sale was disclosed in a legal filing with the securities & exchange commission , which is accessible through this hyperlink . corporate insiders own 23.70 % of the company 's stock . a number of large investors have recently made changes to their positions in lmat . conestoga capital advisors llc grew its stake in shares of lemaitre vascular by 51.2 % in the third quarter . conestoga capital advisors llc now owns 854,644 shares of the medical instruments supplier 's stock valued at $ 31,981,000 after buying an additional 289,575 shares in the last quarter . vanguard group inc. . ",
        "grew its stake in shares of lemaitre vascular by 23.5 % in the second quarter . vanguard group inc. . now owns 815,580 shares of the medical instruments supplier 's stock valued at $ 25,462,000 after buying an additional 155,249 shares in the last quarter . janus henderson group plc acquired a new stake in shares of lemaitre vascular in the second quarter valued at about $ 4,661,000 . bank of new york mellon corp grew its stake in shares of lemaitre vascular by 137.9 % in the second quarter . bank of new york mellon corp now owns 210,628 shares of the medical instruments supplier 's stock valued at $ 6,574,000 after buying an additional 122,076 shares in the last quarter . ",
        "finally , principal financial group inc. . acquired a new stake in shares of lemaitre vascular in the second quarter valued at about $ 3,197,000 . institutional investors own 69.24 % of the company 's stock . lemaitre vascular opened at $ 31.96 on friday . the company has a market capitalization of $ 607.97 , a price-to-earnings ratio of 40.97 , a p/e/g ratio of 2.36 and a beta of 0.54 . lemaitre vascular has a 12 month low of $ 19.82 and a 12 month high of $ 39.88 . illegal activity warning : this news story was originally published by american banking news and is owned by of american banking news . ",
        "if you are accessing this news story on another website , it was copied illegally and republished in violation of us and international copyright and trademark legislation . the correct version of this news story can be viewed at lemaitre vascularlemaitre vascular , inc is a provider of medical devices for the treatment of peripheral vascular disease . the company develops , manufactures and markets medical devices and implants used primarily in the field of vascular surgery . it is engaged in the design , marketing , sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment . ",
        "get a free copy of the zacks research report on lemaitre vascular for more information about research offerings from zacks investment research , visit zacks . comreceive news & ratings for lemaitre vascular daily - enter your email address below to receive a concise daily summary of the latest news and analysts ' ratings for lemaitre vascular and related companies with marketbeat . com 's free daily email newsletter .   "
    ]
}